Immunotherapeutic kit for the treatment of tumors
CA 2431199 C · Owner: Centro De Inmunologia Molecular · Inventors: Perez Rodriguez, Rolando; Gonzalez Marinello, Gisela Maria; Beausoleil Delgado, Irene
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the field of immunology more specifically to cancer , immunotherapy especially using immunotherapeutic combinations and treatment methods to prevent the growth of tumor cell and/or eliminate said cells. The methods disclosed in the invention are based on the blockage of kinase protein receptors in tyrosine residues (RTK) and the ligands for said receptors. The invention describes immunotherapeutic combinations which block the RTK receptors and/or their ligands by combining active and/or passive immunotherapy against said receptors. The methods disclosed can be used in patients with different clinical states of tumors of epithelial origin which overexpress …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 6, 2001 and granted October 4, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 6, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 6, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.